Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR | 
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC | 
| Node | LOC442271 | 
| Upstream (Parents) | 
|---|
| (<<) ISLR → LOC442271 | 
| (<<) ENTPD1 → LOC442271 | 
| (<<) LPCAT1 → LOC442271 | 
| (<<) PRLH → LOC442271 | 
| (<<) PODXL → LOC442271 | 
| (<<) MED31 → LOC442271 | 
| Downstream (Children) | 
|---|
| LOC442271 → S100A12 (>>) | 
| LOC442271 → CES4 (>>) | 
| LOC442271 → BMP3 (>>) | 
| LOC442271 → HIST2H3PS2///HIST1H2BN///HIST1H2BL (>>) | 
| LOC442271 → ATP2B3 (>>) | 
| LOC442271 → CRYGC (>>) | 
| LOC442271 → YSK4 (>>) | 
| LOC442271 → GATA1 (>>) | 
| LOC442271 → FGF4 (>>) | 
| LOC442271 → PRLH (>>) | 
| LOC442271 → MED31 (>>) | 
| LOC442271 → N4BP3 (>>) | 



